Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

Trial Profile

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Buprenorphine/naloxone (Primary) ; Opioid analgesics
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2016 Status changed from active, no longer recruiting to discontinued.
    • 25 Feb 2016 Planned End Date changed from 1 Oct 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
    • 10 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top